Disparities in hepatitis B vaccine funding in Australian jurisdictions: limiting access for priority populations

Publisher： John Wiley & Sons Inc

E-ISSN： 1753-6405|39|2|192-192

ISSN： 1326-0200

Source： AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, Vol.39, Iss.2, 2015-04, pp. : 192-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to improve access to therapy in hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 115-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Different HBs Antibody versus Lymphoproliferative Responses after Application of a Monovalent (Hepatitis B) or Combined (Hepatitis A + Hepatitis B) Vaccine

By  

International Archives of Allergy and Immunology, Vol. 123, Iss. 4, 2000-12 ,pp. : 349-353

Karger

Access to resources Recommend Favorite

Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients

By  

Nephron Clin Pract, Vol. 103, Iss. 3, 2006-03 ,pp. : c89-c93

Karger

Access to resources Recommend Favorite

Hepatitis B vaccine in bowel disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 92-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Malaria Vaccine Candidate Based on a Hepatitis B Virus Core Platform

By  

Intervirology, Vol. 45, Iss. 4-6, 2003-01 ,pp. : 350-361

Karger

Access to resources Recommend Favorite